Onyx Pharmaceuticals News

's stock had its "hold" rating reaffirmed by research analysts at TheStreet in a report released on Monday, AnalystRatings.Net reports.

Bank of America Merrill Lynch 2013 Health Care Conference Onyx will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Tuesday, May 14, 2013 at 9:20 a.m. Pacific Time .

A number of other firms have also recently commented on ONXX. Analysts at Barclays Capital raised their price target on shares of Onyx Pharmaceuticals from $93.00 to $98.00 in a research note to investors on Wednesday.

The firm currently has a "buy" rating on the stock. ONXX has been the subject of a number of other recent research reports.

Aveo Pharmaceuticals Inc. failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as existing treatments.

Bill Gunderson is a San Diego money manager, financial talk show host, creator of the Best Stocks Now app and editor of the Gunderson Report .

Jet Life Penny Stocks provides investors with the Best penny stock alerts on a regular basis.

Aveo Pharmaceuticals Inc.'s lead product candidate, a kidney cancer drug, may need another clinical trial to assess the benefit, U.S. regulators said.

Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase raised their price target on shares of Onyx Pharmaceuticals from $100.00 to $105.00 in a research note to investors on Thursday, March 28th.